There is a new study beginning the spring/summer of 2007 in Warrenton, VA to address the excessive dry mouth patients experience after undergoing radiation treatment for head & neck cancer. The primary objective is to assess the impact of the drug Evoxac (cevimeline) on salivary flow at a dose of 30mg three times daily. Of note, this drug and dosage has already been approved by the FDA for treatment of dry mouth in patients with Sjogren's syndrome, an autoimmune disease that causes dry …
Home
»
Posts filed under
evoxac
Showing posts with label evoxac. Show all posts
Showing posts with label evoxac. Show all posts
Subscribe to:
Posts
(Atom)